Consumer Justice Foundation Discusses Actos Bladder Cancer Lawsuit Filed against Takeda Pharmaceuticals and Eli Lilly and Company Alleging Actos Side Effects

Share Article

The Consumer Justice Foundation, a for-profit corporation consisting of professional consumer advocates whose mission is to educate the public with regards to dealing with large insurance companies and pharmaceutical companies and whose URL can be found at http://www.SideEffectsRX.com, hereby discusses an Actos bladder cancer lawsuit filed against co-defendants Takeda Pharmaceuticals and Eli Lilly and Company that alleges that the plaintiff in the case developed bladder cancer after taking Actos to treat diabetes.

“Upon information and belief, in the last year, the medication had global sales of $4.8 billion and accounted for approximately 27 percent of Takeda's revenue.”

The Consumer Justice Foundation, which is a for-profit company that is comprised of a team of professional consumer advocates who provide a free online educational and informational resource designed to provide important updates to consumers regarding dealing with insurance companies and alleged dangers of using pharmaceutical medications, hereby discuss the specifics of an Actos lawsuit that was recently filed in Illinois against co-defendants Takeda Pharmaceuticals and Eli Lilly and Company in which the plaintiff alleges that the Actos bladder cancer lawsuit was filed because he developed bladder cancer after using the medication.

This Actos bladder cancer lawsuit, which was filed in September in the Madison County, Illinois Circuit Court and with the case number of 2011L 000934, was filed by plaintiffs Robert and Jewell Bettorf. The complaint alleges that Robert Bettorf began taking Actos in order to treat the symptoms of his type II diabetes in 2007. The case further alleges that Mr. Bettorf was not aware at the time that using Actos for more than 12 months increased his risk of developing bladder cancer.

Mr. Bettorf was diagnosed with bladder cancer, and the Actos lawsuit that was filed alleges that the defendants were aware of this heightened risk of developing this disease as early as 2005 but did not take steps to warn consumers of this risk. The complaint specifically alleges that at least two Actos side effects studies were completed by 2005 but that the defendants did not publish the results of those studies. Mr. Bettorf was diagnosed with bladder cancer in 2008.

Finally, the lawsuit alleges that the warnings regarding the link between Actos and bladder cancer were not issues publicly because Actos generated a large amount of revenue for the defendants. “Upon information and belief, in the last year, the medication had global sales of $4.8 billion and accounted for approximately 27 percent of Takeda's revenue.”

The plaintiffs seek a judgment in excess of $50,000 and further seek damages for strict liability, negligent failure to warn, negligent design defect, negligence, breach of express warranty, breach of implied warranty, negligent misrepresentation, violation of Illinois Consumer Protection Laws and loss of consortium.

About the Consumer Justice Foundation
The Consumer Justice Foundation, whose Web site can be found at http://www.SideEffectsRX.com, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Faith Anderson
Visit website